Seema Kesar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Seema Kesar has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Kirtika Madan
Department of Pharmacy, Banasthali University, Banasthali, Rajasthan, 304022, India
1 shared publication - Mansi Madan
Medical Department, All India Institute of Medical Sciences, Jodhpur, Rajasthan, 342005, India
1 shared publication Monika Chauhan
Banasthali University, Faculty of Pharmacy, Department of Pharmacy, Rajasthan, India
1 shared publication- Neha Chauhan
Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, 304022, India
1 shared publication Pooja Mishra
Banasthali University, Faculty of Pharmacy, Department of Pharmacy, Rajasthan, India
1 shared publicationSarvesh K. Paliwal
Banasthali University, Faculty of Pharmacy, Department of Pharmacy, Rajasthan, India
1 shared publication
Latest Publications
- 1 October 2023
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 23 (12) , 1491-1504
Metabolic Syndrome: The Constellation of Co-morbidities, A Global Threat
Background: Metabolic syndrome, also referred to as Syndrome X or obesity syndrome is a cluster of diseases prevalent worldwide in both developed and developing countries. According to WHO, it is referred to as a pathological condition wherein multiple disorders are manifested in the same individual. These include hypertension, hyperglycemia, dyslipidemia and abdominal obesity. Aims:: Metabolic syndrome is one of the most serious non-communicable health hazards that have gained pivotal importance in the present scenario. The increasing prevalence affecting around 25 % of the world populace, mainly attributes to the acceptance of western culture, i.e. the intake of high-calorie food along with a substantial decrease in manual labor and adoption of sedentary lifestyles. Therefore, its timely prevention and management are the dire need in the present scenario. Methods: For successful accomplishment of the present review, an exhaustive analysis was performed utilizing a pool of previous related literature. The terms used during the search included ‘metabolic syndrome, prevalence, etiology, current pharmacotherapy for metabolic syndrome, etc. PUBMED, Medline and SCOPUS were explored for the study of abstracts, research and review papers in the quest for related data. The articles were downloaded and utilized for a meta-analysis study approach. Conclusion: In this review, an attempt was made to apprehend and summarize the epidemiology and treatment strategies for metabolic syndrome with a better understanding of its pathogenesis. It was postulated that an early diagnostic approach and subsequent line of treatment is required to prevent the deterioration of an individual’s health and life.
- 1 October 2023
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 23 (12) , 1491-1504
Metabolic Syndrome: The Constellation of Co-morbidities, A Global Threat
Background: Metabolic syndrome, also referred to as Syndrome X or obesity syndrome is a cluster of diseases prevalent worldwide in both developed and developing countries. According to WHO, it is referred to as a pathological condition wherein multiple disorders are manifested in the same individual. These include hypertension, hyperglycemia, dyslipidemia and abdominal obesity. Aims:: Metabolic syndrome is one of the most serious non-communicable health hazards that have gained pivotal importance in the present scenario. The increasing prevalence affecting around 25 % of the world populace, mainly attributes to the acceptance of western culture, i.e. the intake of high-calorie food along with a substantial decrease in manual labor and adoption of sedentary lifestyles. Therefore, its timely prevention and management are the dire need in the present scenario. Methods: For successful accomplishment of the present review, an exhaustive analysis was performed utilizing a pool of previous related literature. The terms used during the search included ‘metabolic syndrome, prevalence, etiology, current pharmacotherapy for metabolic syndrome, etc. PUBMED, Medline and SCOPUS were explored for the study of abstracts, research and review papers in the quest for related data. The articles were downloaded and utilized for a meta-analysis study approach. Conclusion: In this review, an attempt was made to apprehend and summarize the epidemiology and treatment strategies for metabolic syndrome with a better understanding of its pathogenesis. It was postulated that an early diagnostic approach and subsequent line of treatment is required to prevent the deterioration of an individual’s health and life.
- 1 June 2019
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 16 (2) , 141-154
Quantitative Structure–Activity Relationship Analysis of Selective Rho Kinase Inhibitors as Neuro-regenerator Agents
To understand the role of Rho (serine/threonine) kinases in the treatment of neurological segments, attempts have been made to find potent inhibitors of Rho enzyme by a 2D quantitative structure-activity relationship (QSAR) model. QSAR studies were executed on urea-based scaffolds from aniline and benzylamine analogues, which were aligned for generation of a chemometric-based model. Multivariate statistical approaches were applied including linear and nonlinear analysis such as multiple linear regression, partial least square and artificial neural network for the generation of model, and also an application of (in silico) absorption, distribution, metabolism, excretion studies was performed to ascertain the novelty and drug-like properties of the intended molecules. Ligand based analysis was implemented and showed excellent statistical relevance such as S value=0.38, F value=48.41, r=0.95, r²=0.91, and r²cv=0.86. Five illuminating variables, i.e., vesicle-associated membrane protein (VAMP) polarization YY component (whole molecule), VAMP dipole Y component (whole molecule), VAMP dipole Z component (whole molecule), Kier ChiV6 path index (whole molecule), and moment of inertia 2 size (whole molecule), were found and they have a profound influence on the potency of the compounds. The values of standard statistical parameters reveal the predictive power and robustness of this model and also provide valuable insight into the significance of five descriptors. The acquired physicochemical properties (electronic, topological, and steric) show the important structural features required for activity against Rho kinase. After performing Lipinski's rule of five on urea-based derivatives no molecule was violating the rule. Therefore, these features can be effectively employed for the modeling and screening of active neurological agents as novel Rho kinase inhibitors.
- 1 June 2019
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 16 (2) , 141-154
Quantitative Structure–Activity Relationship Analysis of Selective Rho Kinase Inhibitors as Neuro-regenerator Agents
To understand the role of Rho (serine/threonine) kinases in the treatment of neurological segments, attempts have been made to find potent inhibitors of Rho enzyme by a 2D quantitative structure-activity relationship (QSAR) model. QSAR studies were executed on urea-based scaffolds from aniline and benzylamine analogues, which were aligned for generation of a chemometric-based model. Multivariate statistical approaches were applied including linear and nonlinear analysis such as multiple linear regression, partial least square and artificial neural network for the generation of model, and also an application of (in silico) absorption, distribution, metabolism, excretion studies was performed to ascertain the novelty and drug-like properties of the intended molecules. Ligand based analysis was implemented and showed excellent statistical relevance such as S value=0.38, F value=48.41, r=0.95, r²=0.91, and r²cv=0.86. Five illuminating variables, i.e., vesicle-associated membrane protein (VAMP) polarization YY component (whole molecule), VAMP dipole Y component (whole molecule), VAMP dipole Z component (whole molecule), Kier ChiV6 path index (whole molecule), and moment of inertia 2 size (whole molecule), were found and they have a profound influence on the potency of the compounds. The values of standard statistical parameters reveal the predictive power and robustness of this model and also provide valuable insight into the significance of five descriptors. The acquired physicochemical properties (electronic, topological, and steric) show the important structural features required for activity against Rho kinase. After performing Lipinski's rule of five on urea-based derivatives no molecule was violating the rule. Therefore, these features can be effectively employed for the modeling and screening of active neurological agents as novel Rho kinase inhibitors.